{"id":"W3104819140","doi":"10.1136/jitc-2020-sitc2020.0428","title":"428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Vismodegib; Internal medicine; Clinical endpoint; Interim analysis; Basal cell carcinoma; Progression-free survival; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy; Adverse effect; Basal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002589799,0.000340135,0.0006605349,0.0002077749,0.0000710785,0.00003675068,0.0001749694,0.0001122542,0.000001300236],"category_scores_gemma":[0.0007331726,0.000266149,0.0001345962,0.0005152943,0.0001731042,0.00001209019,0.00009176711,0.0001218816,0.000001185681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003229282,"about_ca_system_score_gemma":0.0001735328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002956717,"about_ca_topic_score_gemma":0.00008719794,"domain_scores_codex":[0.9979314,0.00007707924,0.0006454673,0.0007064319,0.0002849085,0.0003547381],"domain_scores_gemma":[0.9986241,0.00004601654,0.0003333448,0.0003253949,0.0002155774,0.0004555464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03979018,0.003933584,0.2824783,0.002765852,0.003646856,0.0002199197,0.01297251,0.01064834,0.628253,0.00002269762,0.01302107,0.002247635],"study_design_scores_gemma":[0.01102948,0.00786678,0.1357712,0.0003307151,0.0007527742,0.00000104222,0.0007115796,0.0008667976,0.8401536,0.000006696702,0.001844644,0.0006647296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978448,0.0001474913,0.0001015057,0.0005085811,0.00006380789,0.0008143836,0.0004676517,0.00001327634,0.00003849393],"genre_scores_gemma":[0.9978396,0.000006512205,0.001082881,0.0005362239,0.00006730432,0.00007272125,0.0003164341,0.00004002002,0.00003829677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2119005,"threshold_uncertainty_score":0.9999791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02856484540316573,"score_gpt":0.270789013981223,"score_spread":0.2422241685780573,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}